Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peng Xu

5PUBLICATIONS

12CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersNeurosciences not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Aug 29, 2024

Revitalizing Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches.

Maoxin Lv, Shihao Shang, Kepu Liu

|Jun 11, 2024

Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016).

Peng Xu, Wen Luo, Jingjing Hu

|Dec 10, 2020

Overexpression of <i>FAM234B</i> Predicts Poor Prognosis in Patients with Luminal Breast Cancer.

Lijuan Lyu, Meng Wang, Yi Zheng

|May 06, 2020

Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer.

Peng Xu, Jia Yao, Zhen Li

|Oct 22, 2019

Association Between Genetic Polymorphisms In <i>TYMS</i> And Glioma Risk In Chinese Patients: A Case-Control Study.

Li Yao, Linghui Zhou, Yujiao Deng

Pageof 1

Frequent Collaborators

4 joint publications

Zhijun Dai

3 joint publications

Linghui Zhou

2 joint publications

Yujiao Deng

2 joint publications

Hao Wu

1 joint publications

Yi Zheng

1 joint publications

Wen Luo

1 joint publications

Xiaobin Ma

1 joint publications

Qian Hao

1 joint publications

Shuai Lin

1 joint publications

Huafeng Kang

Frequent Collaborators

4 joint publications

Zhijun Dai

3 joint publications

Linghui Zhou

2 joint publications

Yujiao Deng

2 joint publications

Hao Wu

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

See more related videos